The use of radioactive-labelled fats in the study of fat absorption was first described by Stanley and Thannhauser in 1949 . They suggested that after the oral administration of labelled fat an index ofabsorption could be obtained from a measurement of either the subsequent blood radioactivity curve or the amount of unabsorbed radioactivity in the faeces. After initial enthusiasm (Baylin, Sanders, Isley, Shingleton, Hymans, Johnston, and Ruffin, 1955; Ruffin, Shingleton, Baylin, Hymans, Isley, Sanders, and Sohmer, 1956; Ruffin, Keever, Chears, Shingleton, Baylin, Isley, and Sanders, 1958 ) the use of the blood curve has been rejected by most investigators because its peak and shape were shown to be influenced by factors other than that due to fat absorption (Isley, Sanders, Baylin, Sharpe, Hymans, Ruffin, Shingleton, and Wilson, 1957; Mohamed and Hume, 1959; and Vidinli, Texter, and Cooper, 1963) . More recently, the use of the measurement of faecal radioactivity after oral administration of labelled fat has also fallen into disrepute, chiefly because several workers found inconsistent correlation with chemical faecal fat estimation (eg, Pimparkar, Tulsky, Kalser, and Bockus, 1960; Cox, 1961; Clark, Crooks, Dawson, and Mitchell, 1964) .
In this report a new attempt has been made to correlate the measurement of faecal radioactivity after the oral administration of 1311-labelled triolein,
Received for publication 29 October 1970. faecal fat using the chemical method of van de Kamer, Huinink, and Weijers (1949) , and total faecal lipid measured gravimetrically after extraction of the whole faecal homogenate. A special feature of the series is the use of faecal markers to correct for any loss of faeces during the investigation as it has been suggested, although not tested, that part of the unreliability of the test might be due to a failure to obtain a complete faecal collection. In order to confirm that complete faecal recovery had been achieved, anunabsorbedradioactivelylabelledmarkersubstance (51Cr chromium sesquioxide or "Sc scandium chloride) was given orally together with the 113T-labelled triolein. It was shown that the marker and the unabsorbed fat pass through the gut at the same rate. Therefore the amount of marker radioactivity recovered as a percentage ofthe administered amount indicates the percentage recovery of the activity corresponding to the radioactive triolein. Two methods for the estimation of faecal fat were used as it is also possible that the discrepancies between radioactive fat absorption tests and faecal fat measured by chemical means are due to the chemical estimation techniques. The usual method (van de Kamer et al, 1949) involves titration for fatty acids after saponification, acidification, and extraction from a small aliquot of faecal homogenate. Possible errors in this method include those inherent in the taking of small samples and those due to the 506 Unabsorbed radioactive marker substances in re-assessment of radioactive triolein test offat absorption 507 assumption of a mean molecular weight for faecal fatty acids (Andersen, 1945) .
Materials and Methods
Eighty-three inpatients from general medical wards were used in this investigation. They consisted of 31 patients with known gastrointestinal disorders of various kinds (not necessarily associated with steatorrhoea) and 52 patients without known gastrointestinal disease ('normals'). The object of the investigation was explained to each of them, and all agreed to take part.
A standard procedure was adopted for the administration of tracer substances and for the subsequent collection of faeces. All patients received an oral dose of marker (51Cr-chromium sesquioxide or 4"Scscandium chloride) but only 62 of them received both marker and 1311-labelled triolein. Each patient was allowed a normal ward diet before and during the test but no attempt was made to measure the actual quantity eaten. The daily fat content of the diet was estimated to be between 80 and 120 g per day.
The 
RADIOACTIVE ANALYSIS
The radioactivity in each container was measured using a large volume 47r plastic scintillation detector (Smith, Clarke, and Reed, 1967) . The proportion of the total radioactivity due to the respective isotopes was calculated in the normal manner by measuring the count rate from each container at two pulse height analyser window settings and comparing them against standard activities of 1311 and -"Cr (or "4Sc). All stools from the beginning of the collection period were counted until two successive stools each contained less than 1 % of the administered activity of each isotope. The cumulative counts for each isotope were then expressed as percentages of the administered dose.
CHEMICAL ANALYSIS
The same collections were used for chemical faecal fat analysis. The whole faecal collection from each individual was bulked together and homogenized with water to give a volume of between 1 5 and 3-01 dependent upon the original volume and consistency of the faeces.
Method A A 20 ml aliquot of the homogenate was removed immediately after homogenization for analysis of fat content by the method of van de Kamer et al (1949) . It was then shaken for five minutes in a large separating flask with a 1:4 mixture of diethyl ether and light petroleum ether (BP 40-60'C) (Zuckerman, Zymaris, and Natelson, 1949; Henry, 1964) . Continuous extraction was then carried out in the apparatus shown in Figure 1 . Extraction took eight hours or longer and was continued until one hour after the ether leaving the faecal residue container became colourless. The faecal residue was intermittently stirred during extraction. After extraction the ether was evaporated from the lipid which was then weighed after drying to constant weight in a vacuum over anhydrous calcium chloride. In order to test the efficiency ofextraction, aliquots of several of the dried faecal residues were reextracted for six hours in a Soxhlet apparatus. The small quantities of lipid recovered in this way showed that more than 99 % of the fat soluble in the solvent system used must have been removed.
In the following sections the faecal fat measured by method A will be called fat A and that by method B will be called fat B. All of the 83 patients in whom faecal collection was attempted were given a radioactive marker. In 40 the marker was 5'Cr-chromium sesquioxide and in 43 it was 46Sc-scandium chloride. The excretion rates of the two marker substances were identical. The completeness of faecal collection was judged from the recovery of the marker in the faeces; the amounts are shown in Figure 2 . They varied from less than 10% (8 cases) to between 100 and 110% (16 cases Figure 4a and b. Values from two additional cases with gross steatorrhoea are also included although the marker recovery was less than 'complete', ie, below 90% but above 85%.
The results were either normal (21 cases) or abnormal (14 cases) by all three methods with one +These cases had a faecal recovery between 85 % and 90%. All other cases had a faecal marker recovery greater than 90%. Figure 5a and b. In the 20 with results within the normal range the mean ratio fat A/fat B was 0-68 ± 0-12 and in the 13 with abnormal results it was 0-87 ± 0 09. Variation of the ratios for individual cases in the normal group is large (range 0-38-0 91) but in the abnormal group the range is small (0 70-0 95).
In two patients given 46Sc-scandium chloride and in whom body retention and urine excretion of 46Sc was measured, 0 85 + 0-1% and 0-66 ± 0-1% respectively was retained at the end of seven days, and in each the cumulative urinary excretion was less than 05 00.
Discussion
The upper limits (mean + 2 SD) of the normal range for faecal fat and 1311-triolein from these data may be compared in Table III with those adopted by others. While the upper limit for the fat A (van de Kamer) method (6-81 g/day) is similar to that of most authors, the upper limit for 131I-triolein is much lower, and is comparable only with those of Cox (1963) and Clark et al (1964) .
Comparison of the results of fat A with those of fat B demonstrates a close relationship with a systematic difference between the two methods in the abnormal range. Fat B (total lipids) gives results which are consistently higher than those of fat A (Fig. 5a ). In the normal range variation of individual results is much larger, and the mean ratio fat A: fat B is lower (Fig. Sb) . There is also no correlation between the 1311-triolein results and either method of fat estimation in the normal group (Figs. 4a and b) . Several factors may contribute to this: (a) inaccura- (Wollaeger, Comfort, and Osterberg, 1947, Cooke, Thomas, Mangall, and Cross, 1953; Weijers and van de Kamer, 1953) .
In distinguishing between normal and abnormal degrees of fat excretion, however, the inconsistencies in the relationship between the van There is evidence that radioactive triolein fulfils, this criterion (Turner, 1958; van Handel and Zilversmit, 1958) . The test would be invalidated if the 1311 label were split off the triolein while in the gut but available evidence suggests that this does not occur. Balint, Pendower, and Ramsey (1960) and Beres, Wenger, and Kirsner (1957) found that in laboratory conditions iodinated triolein was stable for one hour in various gastrointestinal secretions, and Cox (1961) demonstrated that the bond was relatively stable in faeces although he did show some splitting of the iodine bond when the triolein was incubated for four hours in duodenal juice. However, the exposure to the action of duodenal enzymes is likely to be considerably less than four hours.
It has been suggested that part of the faecal radioactivity after oral administration of radioactive triolein might be derived from free iodide excreted from the blood into the lower bowel after the absorption and splitting of the triolein. Several studies, however, have shown that there is no free radioactive iodine in the stools, all the radioactive material being in ether-soluble material (Ruffin et al, 1956 ; Mohamed and Hume, 1959) .
Thus no evidence has been produced which in- (Lubran and Pearson, 1958; Cox, 1961) Previous investigators were unable to test the completeness oftheir faecal collections. In the present study the use of a radioactive marker substance enabled estimations to be made of the completeness of the collection of those stools corresponding to the test dose of radioactive triolein. The validity of a marker depends upon its nonabsorption in the gut and upon it travelling through the gut at the same rate as unabsorbed fat. Previous work has shown that neither chromium sesquioxide (Reifenstein, Albright, and Wells, 1945; Whitby and Lang, 1960; Hansky and Connell, 1962; Sassoon, 1966) nor scandium chloride (Pearson, 1966; Ogg, Pearson, and Veall, 1968) is absorbed from the gastrointestinal tract. Results in this series with both scandium chloride and chromium sesquioxide indicate that these markers travel through the gut at very nearly the same rate as fat in the form of triolein (Fig. 3) . Although there were slight differences in marker and triolein transit times in individual cases, these differences were insignificant from the point of view of assessing the completeness of triolein recovery.
The patients studied were on general medical wards and exceptional efforts to obtain complete collection were not made because it was wished to assess the percentage of routine faecal collections which were complete. However, both the patients and the ward staff knew that a special investigation was in progress and it is probable that this would improve routine faecal fat collections. Nevertheless in only 40 out of 83 cases (48-2 %) was a complete collection obtained. It is appreciated that the technique used only detected loss of stools referrable to the test dose; some of the cases in which complete recovery of isotopes was obtained could have been incomplete collections because non-isotope-containing stools were lost.
The high percentage (52%) of incomplete faecal collections suggests a major source of error in the triolein test when it is performed on general wards. Even in metabolic units the collection cannot be assumed to be complete. Rose (1964) , using continuous chromium sesquioxide feeding as an indicator in calcium studies, reported incomplete faecal collections in seven out of 21 patients studied on a metabolic unit. In most published investigations of the triolein test the patients have either been on general medical wards or have been studied as outpatients.
These experimental results appear to justify the conclusion that the 1311-triolein excretion test is as accurate as the direct faecal fat measurement in distinguishing normal from abnormal and in discriminating degrees of abnormality. Previous con-Unabsorbed radioactive marker substances in re-assessment of radioactive triolein test offat absorption 513 fusion probably resulted from incomplete faecal collections-always a likely source of error. Both '311-triolein and faecal fat measurement are vulnerable to error in faecal collection and it would appear to be essential to use a non-absorbable marker as a check against loss during collection. Provided that collection is complete, both methods give comparable results, and there does not seem to be a valid reason for the suspicion that 1311-triolein absorption is not closely related to total fat absorption. This being so, the 1311-triolein excretion test may commend itself again because of its inherent technical advantages. 514 to 750 kev (utilizing the higher y-ray energy of 13L1) and from 250 to 400 kev. Unfortunately the latter condition envelopes both the chromium y-ray energy and the most abundant 1311 y-ray energy so that the iodine contribution to the total counts recorded in this window was large. It was also found that under high count rate conditions pulse summation occurred which produced a higher count rate in the upper energy window than that due solely to the iodine content of the sample and was dependent upon the total activity in the sample. When scandium chloride was substituted for chromium sesquioxide as the faecal marker the R. K. Ditchburn, A. H. Smiih, and C. J. Hayter operating conditions were changed to a window setting between 1 0 and 1 -2 Mev and to an integral setting with a lower level of 250 kev. The latter setting measures both the 131I and 46Sc contents of the sample but it was found to be the setting which yielded the most accurate results at high count rates. Using samples of known activity it was found that the 1311 content of a sample could be determined with an error of less than 10% provided that the scandium activity was less than twice the iodine activity in a sample. The minimum measurable quantity of either isotope was less than 1 00 of the administered dose. 
